Delving into the probe findings, the bench highlighted the pharmacist’s wrongful dispensing of Coldrief syrup instead of the doctor-prescribed Nexstro-DS. Shockingly, no billing records existed, and the accused allegedly destroyed crucial evidence like 66 syrup bottles to cover tracks.

As the gatekeeper of pharmaceutical integrity, the pharmacist bears the onus of accurate distribution and documentation to safeguard lives. Dr. Soni’s unauthorized prescription of the hazardous syrup to minors further exposed glaring ethical breaches. These combined failures in protocol unleashed devastation.

The syrup, contaminated with toxic diethylene glycol from its manufacturing source, ravaged children’s kidneys, leading to more than 26 fatalities at Parasiya Community Health Centre from August to October 2025. The state swiftly imposed a ban on October 4, 2025.

Investigations reveal a web of commission-driven motives linking the pharmacist, doctor, and associates. Detained since October 13, 2025, the prime evidence against them invokes serious charges under key legal provisions including the Drugs and Cosmetics Act.

The court’s firm stance signals zero tolerance for such negligence amid a probe exposing regulatory chinks in drug supply chains. While this decision is bail-specific, it amplifies calls for comprehensive reforms to prevent future tragedies, ensuring no child falls victim to poisoned remedies.

Dr. Soni is implicated in the deaths of 11 children due to a toxic Coldrif syrup he prescribed. This has caused widespread concern and a thorough investigation is underway. The investigation revealed that Dr. Soni prescribed medications that adversely affected infants’ kidneys, leading to their deaths.

Health Commissioner Tarun Rathi stated in the suspension order issued on Sunday, “Dr. Praveen Soni, a pediatrician posted at the Civil Hospital in Parasia, Chhindwara district, was found to be engaged in private practice, during which he prescribed certain medications to infants brought to him for treatment. Several of these children subsequently developed high fever and difficulty urinating, and some tragically died.”

SP Ajay Pandey reported to the media that a case has been filed against Dr. Soni under sections 105 BNS, 276 BNS, and 27(a) of the Drugs and Cosmetics Act. Dr. Soni treated the majority of the affected children. He had prescribed the Coldrif medication. Based on this, he has been made an accused in the case. The manufacturing company, Srisan Pharmaceuticals of Tamil Nadu, has also been named as a main accused. The doctor is currently in police custody.